Barratt Developments Appoints Countryside Executive Mike Scott As Executive Director And CFO

Barratt Developments (BDEV.L) said that it has appointed Mike Scott, who is currently the Chief Financial Officer of Countryside Properties, as an Executive Director and Chief Financial Officer. The date he will join Barratt is currently being finalized and will be announced in due course.

Mike Scott joined Countryside as Group Financial Controller in 2014. Prior to joining Countryside, Mike held a number of senior finance roles from 2010 until 2014 at J. Sainsbury Plc, including latterly as Head of Investor Relations. Mike qualified as a chartered accountant with PricewaterhouseCoopers LLP in 2002.

Barratt noted that Jessica White will step down from the Board on 30 June 2021 and thereafter David Thomas, Barratt Group Chief Executive, who previously held the role of Barratt Chief Financial Officer for six years until July 2015, will assume temporary responsibility for the finance function. He will be supported by John Flynn, Group Operations Financial Controller and Jonathan Rumble, Group Financial Controller.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
MTD Products Inc. is recalling 1,774 units of walk-behind self-propelled lawn mowers for potential risk of fire hazard, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. The company said the lawn mower can leak fuel when it is stored in the upright (vertical) storage position to pose a fire hazard. Nike Inc. announced its plans to exit the Russian market completely following Russia's ongoing war against Ukraine, reports said. The sportswear major, with more than 100 stores in the country, had suspended operations there in March. Earlier in March, while suspending operations temporarily, the company had said its customers that it couldn't guarantee product shipments. The U.S. Food and Drug Administration unveiled its action plan to advance drug development for rare neurodegenerative diseases, including Amyotrophic Lateral Sclerosis or ALS, in five years. The FDA plans specific actions such as regulatory science initiatives, enhancements to existing programs and new policy initiatives for the purpose. It will use public-private partnerships...
Follow RTT